ABO-2015

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameABO-2015
Drug Alias NameABO-2015
ClassificationCell and gene therapy > Gene therapy > mRNABiologics > T cell engagers
Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsT cell surface glycoprotein CD3 modulators
TargetsB-lymphocyte antigen CD19T cell surface glycoprotein CD3
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAbogen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbogen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A